THE NOVEL CANNABINOID CB1 ANTAGONIST AM6545 SUPPRESSES FOOD INTAKE AND FOOD-REINFORCED BEHAVIOR

Drugs that interfere with cannabinoid CB1 transmission suppress food-motivated behaviors, and may be useful clinically as appetite suppressants. However, there may also be undesirable side effects (e.g., nausea, malaise, anxiety, depression) that are produced by the current generation of CB1 inverse...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Randall, P.A., Vemuri, V.K., Segovia, K.N., Torres, E. Ferreris, Hosmer, S., Nunes, E.J., Santerre, J.L., Makriyannis, A., Salamone, J.D.
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3522179/
https://ncbi.nlm.nih.gov/pubmed/20713079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2010.07.021
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares